NDC 53217-212

Terazosin

Terazosin Hydrochloride

Terazosin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aidarex Pharmaceuticals Llc. The primary component is Terazosin Hydrochloride.

Product ID53217-212_9bce3e50-1bf2-4d35-8edf-00d5784a1622
NDC53217-212
Product TypeHuman Prescription Drug
Proprietary NameTerazosin
Generic NameTerazosin Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2004-12-20
Marketing CategoryANDA / ANDA
Application NumberANDA075317
Labeler NameAidarex Pharmaceuticals LLC
Substance NameTERAZOSIN HYDROCHLORIDE
Active Ingredient Strength2 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 53217-212-30

30 CAPSULE in 1 BOTTLE (53217-212-30)
Marketing Start Date2004-12-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53217-212-60 [53217021260]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075317
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-12-20
Inactivation Date2020-01-31

NDC 53217-212-90 [53217021290]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075317
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-12-20
Inactivation Date2020-01-31

NDC 53217-212-30 [53217021230]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075317
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-12-20
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TERAZOSIN HYDROCHLORIDE2 mg/1

OpenFDA Data

SPL SET ID:dfcd267e-a965-4942-987a-766a7305f421
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313217

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Terazosin" or generic name "Terazosin Hydrochloride"

    NDCBrand NameGeneric Name
    0615-1338TerazosinTerazosin
    0615-1339TerazosinTerazosin
    10544-289TerazosinTerazosin
    23155-735terazosinterazosin
    23155-736terazosinterazosin
    23155-737terazosinterazosin
    23155-738terazosinterazosin
    33261-211TerazosinTerazosin
    33261-212TerazosinTerazosin
    33261-870TerazosinTerazosin
    42291-820TerazosinTerazosin Hydrochloride
    42291-821TerazosinTerazosin Hydrochloride
    42291-822TerazosinTerazosin Hydrochloride
    42291-823TerazosinTerazosin Hydrochloride
    50090-0657TerazosinTerazosin Hydrochloride
    70518-0342TerazosinTerazosin
    70518-0317TerazosinTerazosin
    70518-0074TerazosinTerazosin
    70518-1875TerazosinTerazosin
    50090-2623TerazosinTerazosin
    50090-2371TerazosinTerazosin
    50090-1559TerazosinTerazosin
    51655-675TERAZOSINTERAZOSIN
    51655-676TERAZOSINTERAZOSIN
    53002-1250TerazosinTerazosin
    53002-1726TerazosinTerazosin
    53002-1727TerazosinTerazosin
    53002-1728TerazosinTerazosin
    53217-212TerazosinTerazosin
    53808-1056TerazosinTerazosin
    59746-383TerazosinTerazosin
    59746-384TerazosinTerazosin
    59746-386TerazosinTerazosin
    59746-385TerazosinTerazosin
    63187-456TerazosinTerazosin
    63187-620TerazosinTerazosin
    66267-325TerazosinTerazosin
    66267-389TerazosinTerazosin
    67296-1264TerazosinTerazosin
    55700-750TerazosinTerazosin
    50268-767TerazosinTerazosin
    50268-765TerazosinTerazosin
    50268-766TerazosinTerazosin
    50268-764TerazosinTerazosin
    71610-478TerazosinTerazosin
    0615-1337Terazosin HydrochlorideTerazosin
    0781-2051Terazosin HydrochlorideTerazosin Hydrochloride
    0781-2052Terazosin HydrochlorideTerazosin Hydrochloride
    0781-2053Terazosin HydrochlorideTerazosin Hydrochloride
    0781-2054Terazosin HydrochlorideTerazosin Hydrochloride
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.